SmartAnalyst experts attended the ESMO CONGRESS 2019, Barcelona (Sept 27-Oct 1), to learn about innovation and development in Oncology.

Based on the data presented at ESMO, what are the implications for treatment paradigms? And, what impact will they have on your pipeline? The Post-ESMO SMARTOncology Insights reports interpret the latest data across 35 tumors, define the market opportunity, and establish the profile required to win.